# Hydroxyurea in Treating Patients With Epstein-Barr Virus-Associated Primary CNS Lymphoma and AIDS

> **NCT00002940** · PHASE2 · COMPLETED · sponsor: **St. Jude Children's Research Hospital**

## Conditions studied

- Lymphoma

## Interventions

- **DRUG:** hydroxyurea

## Key facts

- **NCT ID:** NCT00002940
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-10
- **Primary completion:** 2002-03
- **Final completion:** 2002-03
- **Target enrollment:** — (—)
- **Last updated:** 2012-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002940, "Hydroxyurea in Treating Patients With Epstein-Barr Virus-Associated Primary CNS Lymphoma and AIDS". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00002940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*